Molecular and clinicopathological features of depressed T2 colorectal cancer

Molecular and clinicopathological features of depressed T2 colorectal cancer - Molecular and clinicopathological features of depressed T2 colorectal cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045702

Enrollment

Registered

2021-10-08

Start date

2021-10-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with colorectal cancer who were surgically resected at Showa University Northern Yokohama Hospital between January 2010 and December 2013 and had a pathological depth of T2.

Exclusion criteria

Exclusion criteria: Cases of patients with Familial Adenomatous Polyposis, cases of patients with Lynch syndrome, cases of patients with ulcerative colitis, cases of patients who received preoperative chemotherapy and radiation therapy, cases of patients with missing clinical data

Design outcomes

Primary

Measure	Time frame
Consensus molecular subtypes of depressed colorectal cancer	—

Secondary

Measure	Time frame
Clinicopathological features of depressed colorectal cancer	—

Countries

Japan

Contacts

Public ContactKenichi Mochizuki

Showa University Northern Yokohama Hospital Digestive Disease Center

k.mochizuki@med.showa-u.ac.jp045-949-7000

Outcome results